WO2025231146 - SYNTHETIC SUPERSTOLIDES AND THERAPEUTIC USE THEREOF
National phase entry is expected:
Publication Number
WO/2025/231146
Publication Date
06.11.2025
International Application No.
PCT/US2025/027113
International Filing Date
30.04.2025
Title **
[English]
SYNTHETIC SUPERSTOLIDES AND THERAPEUTIC USE THEREOF
[French]
SUPERSTOLIDES SYNTHÉTIQUES ET UTILISATION THÉRAPEUTIQUE ASSOCIÉE
Applicants **
UNIVERSITY OF IOWA RESEARCH FOUNDATION
NATIONAL INSTITUTE OF HEALTH
JOHN HOPKINS UNIVERSITY
Inventors
JIN, Zhendong
QIAN, Shan
QIU, Haibo
ZHENG, Wei
CHEN, Catherine
XU, Miao
HARTKE, Ruth
SANCHEZ, Phillip, R.
LIU, Jun
Priority Data
63/640,720
30.04.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4622 | |
| EPO | Filing, Examination, Granting | 38839 | |
| Japan | Filing, Examination, Granting | 3328 | |
| South Korea | Filing, Examination, Granting | 4663 | |
| USA | Filing, Examination, Granting | 13460 |
Total:
64,912
Contact Us
Abstract[English]
Provided are compounds of formula (I), preparation thereof, and therapeutic use thereof. The present disclosure provides small molecule compounds and derivatives thereof, including conjugates with antibodies, which can be useful as anti-cancer and/or anti-viral agents.[French]
L'invention concerne des composés de formule (I), une préparation et une utilisation thérapeutique associées. La présente invention concerne des composés à petites molécules et des dérivés de ceux-ci, y compris des conjugués avec des anticorps, qui peuvent être utiles en tant qu'agents anticancéreux et/ou antiviraux.